🇺🇸 Insulin Lispro Injection in United States

26 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaemia — 3 reports (11.54%)
  2. Chills — 3 reports (11.54%)
  3. Dyspnoea — 3 reports (11.54%)
  4. Oedema Peripheral — 3 reports (11.54%)
  5. Pain — 3 reports (11.54%)
  6. Pyrexia — 3 reports (11.54%)
  7. Asthenia — 2 reports (7.69%)
  8. Atrial Fibrillation — 2 reports (7.69%)
  9. Cellulitis — 2 reports (7.69%)
  10. Chest Pain — 2 reports (7.69%)

Source database →

Insulin Lispro Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Insulin Lispro Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Insulin Lispro Injection in United States?

Biocon Limited is the originator. The local marketing authorisation holder may differ — check the official source linked above.